{"name":"Jinming Yu","slug":"jinming-yu","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxOMHhYQXV4ZllWYWZYUVI1aEtNMm1DenRmTUJadHhxb3hETEhZVlp6UDRYbS1wdnFtYWdJa0tUWEtDZ0lOeHBJODlTUGstT3Q1TklRRGVGakp0YURQdXlXWW1YUkk5M0pvTkd4VUp3YmxselFUNE95ampydEJKdnR5YQ?oc=5","date":"2026-01-12","type":"trial","source":"Oncology Pipeline","summary":"AbbVie is next to the VEGF bispecific table | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"AbbVie is next to the VEGF bispecific table | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxNSHBfVUNDTUZ1cTZrbTBpZ2FTNlBnaC1waElRYmtiU1pBWmRHWUhHX1lhUEZnd3pRdFNueVNZc0NaOXRMVmszUkNfR29xTTljZTNLaS0tNHFTTnNJWFlKY3V1Wk5hbExGVVFQcGZHUnMxejk4RktIVWkzZ2tUOXNBVndoOEhOZ2h3b3g3U3J2bU5TRC1jV1lJandvV3FLd2NhZ1VSRXREbmVHRnVPUlNKaE5hbFNuekR6VlQ4UVBYb1lPQkVhd1d1Q2VnbkNDQWpvRjYwb0ttNzY?oc=5","date":"2025-02-13","type":"trial","source":"BioPharma APAC","summary":"Akeso Initiates Phase 3 Trial in China for Cadonilimab as Consolidation Therapy in Advanced NSCLC - BioPharma APAC","headline":"Akeso Initiates Phase 3 Trial in China for Cadonilimab as Consolidation Therapy in Advanced NSCLC","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}